<http://schema.org/description>
"Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel cancer or gastrointestinal stromal tumor following failure of existing treatments."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-11-pill-bowel-cancer-gastrointestinal-stromal.html>